|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.430 USD | +0.16% |
|
-12.99% | -27.10% |
| 05-07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| 05-06 | Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 7 | 9.56 | 8.91 |
| Spread/Res. | -8.14% | -32.74% | -27.83% |
| Spread/Supp. | +2.55% | +48.16% | +11.63% |
| Support | 6.27 | 4.34 | 5.76 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- VNDA Stock
- Charts Vanda Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition